12/3/2013

Scientists developed a nanosponge vaccine to combat methicillin-resistant Staphylococcus aureus infections by targeting the chemical released by the bacteria. "We anticipate that this study will open new possibilities in the preparation of anti-toxin vaccines against the many virulence factors that threaten public health," researchers wrote in the journal Nature Nanotechnology.

Related Summaries